potent pan-PIM kinase inhibitor
oral PD and efficacy in xenograft model
from SBDD of prior lead
Bioorg. Med. Chem. Lett., Oct. 14, 2020
Sanofi, Waltham/Cambridge, MA
“compound 27”
1 min read
“compound 27” (Sanofi oral in vivo pan-PIM kinase inhibitor)
Search By Structure
- BAY 1214784
- BAY 1217224
- CC-90011
- LEO 39652
- OATD-01
- AG-636
- “compound 46”
- “compound 25”
- “lipid 10a”
- BAY-6672
- “compound 27”
- “EST73502”
- CG428
- “compound 34”
Molecules of the Month
2023
2022
2021
2020